Triple artemisinin-based combination therapies for malaria: a timely solution to counter antimalarial drug resistance
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases
Reference9 articles.
1. Malaria eradication within a generation: ambitious, achievable, and necessary;Feachem;Lancet,2019
2. Triple artemisinin-based combination therapies for malaria—a new paradigm?;van der Pluijm;Trends Parasitol,2021
3. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial;van der Pluijm;Lancet,2020
4. Triple artemisinin-based combination therapy artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial;Peto;Lancet Infect Dis,2022
5. Clinical tolerability of artesunate-amodiaquine versus comparator treatments for uncomplicated falciparum malaria: an individual-patient analysis of eight randomized controlled trials in sub-Saharan Africa;Zwang;Malar J,2012
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Understanding the Global Spread of Artemisinin Resistance: Insights from over 100KPlasmodium falciparumSamples;2024-08-24
2. Exploring the interaction of biologically active compounds with DNA through the application of the SwitchSense technique, UV–Vis spectroscopy, and computational methods;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-08
3. Repurposing DrugBank compounds as potential Plasmodium falciparum class 1a aminoacyl tRNA synthetase multi-stage pan-inhibitors with a specific focus on mitomycin;International Journal for Parasitology: Drugs and Drug Resistance;2024-08
4. Mutation of the Plasmodium falciparum Flavokinase Confers Resistance to Roseoflavin and 8-Aminoriboflavin;ACS Infectious Diseases;2024-06-26
5. Mutation of theP. falciparumflavokinase confers resistance to roseoflavin and 8-aminoriboflavin;2024-04-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3